Invokana is not a company; it is a brand name for a medication called canagliflozin. Canagliflozin is a medication used for the treatment of type 2 diabetes. It belongs to a class of medications known...
Invokana is a medication that is prescribed to people who suffer from type 2 diabetes, and it has been advertised in a TV spot titled 'You're Not Alone'. The commercial features a woman who has recently been diagnosed with type 2 diabetes feeling overwhelmed and scared about the diagnosis. She talks about how difficult it is to control her blood sugar levels despite making lifestyle changes such as eating a healthy diet and exercising regularly.
The woman in the commercial is then introduced to Invokana, which is a medication that works by reducing the amount of sugar the kidneys absorb. The commercial emphasizes that while it's normal to feel scared or overwhelmed after being diagnosed with diabetes, there is help available. Invokana promises to be a helpful tool for controlling blood sugar levels and making life with diabetes more manageable.
The ad also features several people who have used Invokana successfully and who offer support and encouragement to those who are struggling with managing their diabetes. The tone of the commercial is one of empathy and understanding, and the message is that nobody with diabetes has to go it alone. With the help of medication like Invokana, it's possible to live a full and healthy life despite the challenges of having diabetes.
Overall, the Invokana TV spot 'You're Not Alone' is a thoughtful and compelling advertisement that seeks to reassure people with type 2 diabetes that there is hope and help available. While it's important to always consult with a doctor before starting a new medication, the commercial provides a valuable introduction to Invokana for those who are considering it as a treatment option.
Invokana TV commercial - Youre Not Alone produced for Invokana was first shown on television on April 5, 2015.
We analyzed TV commercials placed on popular platforms and found the most relevant videos for you: